Health ❯ Medicine

Diabetes

Type 2 Diabetes Ozempic Type 1 Diabetes Insulin Complications GLP-1 Receptor Agonists Weight Loss Insulin Delivery Natural Remedies Diabetes Mellitus

Study Finds Metformin Lowers Blood Sugar by Acting on a Brain Circuit

Mouse data point to a Rap1 pathway in the ventromedial hypothalamus as a target for future diabetes drugs.

Stories older than 24h

Japanese Team Reports Oral Insulin Success in Mice With Peptide Transporter

Pitt Study Identifies SerpinB2 as Key to Protective Fat Macrophages, Pointing to a New Diabetes Treatment Path

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

Reprogrammed Human Stomach Organoids Produce Insulin, Temporarily Control Diabetes in Mice

Small Molecule Blocks RAGE–DIAPH1 Pathway, Reduces Diabetic Tissue Damage in Mice

Nagaland University Study Finds Oral Plant Compound Speeds Diabetic Wound Healing

ISS Tests Find Diabetes Monitors Work in Orbit, Opening Path for Diabetic Astronauts

Study Finds One in Five Ozempic, Wegovy, Mounjaro Users Report Taste Changes

GLP-1 Drugs Linked to Lower Overall Cancer Risk in JAMA Oncology Analysis

MHRA Licenses Teplizumab to Delay Onset of Type 1 Diabetes

Metformin Requires Hypothalamic Rap1 Inactivation to Lower Blood Sugar

3D-Bioprinted Human Pancreatic Islets Enter Preclinical Animal Trials

AI-Guided Cocktails Boost Survival of Transplanted Islet Cells in Diabetic Mice

REDD2 Activation Exacerbates Pancreatic β-Cell Dysfunction and Holds Biomarker Potential

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives